 |
 Previous Article | Next Article 
Volume 16, Number 15,
Issue of August 1, 1996
pp. 4707-4715
Copyright ©1996 Society for Neuroscience
Regulation of ERK ( xtracellular Signal
 egulated  inase), Part of the Neurotrophin
Signal Transduction Cascade, in the Rat Mesolimbic Dopamine System
by Chronic Exposure to Morphine or Cocaine
Received March 26, 1996; revised May 6, 1996; accepted May 9, 1996.
Melissa T. Berhow,
Noboru Hiroi, and
Eric J. Nestler
Laboratory of Molecular Psychiatry, Departments of Psychiatry and
Pharmacology, Yale University School of Medicine, Connecticut Mental
Health Center, New Haven, Connecticut 06508
Local infusion of brain-derived neurotrophic factor (BDNF) into the
ventral tegmental area (VTA) can prevent and reverse the ability of
chronic morphine or cocaine exposure to induce tyrosine hydroxylase
(TH) in this brain region. The present study examined a possible role
for extracellular signal regulated kinases (ERKs), the major effector
for BDNF and related neurotrophins, in morphine and cocaine action in
the VTA. Chronic, but not acute, administration of morphine or cocaine
increased ERK catalytic activity specifically in the VTA. This increase
in ERK activity reflected an increase in the state of phosphorylation
of ERK, with no change in levels of total ERK immunoreactivity. Chronic
infusions of BDNF into the VTA reduced total ERK immunoreactivity with
no change in ERK activity, and also blocked the morphine-induced
increase in ERK activity. These results suggest that chronic BDNF
elicits a compensatory increase in the phosphorylation of the remaining
ERK molecules and thereby prevents any additional increase in response
to drug exposure. Such a role for ERK in morphine action was
demonstrated directly by chronically infusing antisense
oligonucleotides to ERK1 into the VTA. This treatment selectively
reduced levels of ERK1 immunoreactivity in a sequence-specific manner
without detectable toxicity. Intra-VTA infusion of ERK1 antisense
oligonucleotides mimicked the effects of chronic BDNF infusions on ERK
immunoreactivity, ERK activity, and TH immunoreactivity in the VTA
under both control and morphine-treated conditions. The chronic
morphine-induced increases in ERK activity and TH expression in the VTA
also were blocked by local infusion of NMDA glutamate receptor
antagonists, suggesting a role for glutamate in mediating these drug
effects. Together, these findings support a scheme whereby chronic,
systemic administration of morphine or cocaine leads to a sustained
increase in ERK phosphorylation state and activity in the VTA, which,
in turn, contributes to drug-induced increases in TH, and perhaps other
drug-induced adaptations, elicited selectively in this brain
region.
Key words:
morphine;
cocaine;
antisense oligonucleotides;
ERK;
ventral tegmental area;
tyrosine hydroxylase;
BDNF;
NMDA glutamate
receptors
This article has been cited by other articles:
|
|
|
|
 
D. A. Eisinger and H. Ammer
Down-regulation of c-Cbl by Morphine Accounts for Persistent ERK1/2 Signaling in {delta}-Opioid Receptor-expressing HEK293 Cells
J. Biol. Chem.,
December 11, 2009;
284(50):
34819 - 34828.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. A. Macey, E. N. Bobeck, D. M. Hegarty, S. A. Aicher, S. L. Ingram, and M. M. Morgan
Extracellular Signal-Regulated Kinase 1/2 Activation Counteracts Morphine Tolerance in the Periaqueductal Gray of the Rat
J. Pharmacol. Exp. Ther.,
November 1, 2009;
331(2):
412 - 418.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Schumann and R. Yaka
Prolonged Withdrawal from Repeated Noncontingent Cocaine Exposure Increases NMDA Receptor Expression and ERK Activity in the Nucleus Accumbens
J. Neurosci.,
May 27, 2009;
29(21):
6955 - 6963.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. W. Shiflett, R. P. Martini, J. C. Mauna, R. L. Foster, E. Peet, and E. Thiels
Cue-Elicited Reward-Seeking Requires Extracellular Signal-Regulated Kinase Activation in the Nucleus Accumbens
J. Neurosci.,
February 6, 2008;
28(6):
1434 - 1443.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Nunez, M. L. Laorden, and M. V. Milanes
Regulation of Serine (Ser)-31 and Ser40 Tyrosine Hydroxylase Phosphorylation during Morphine Withdrawal in the Hypothalamic Paraventricular Nucleus and Nucleus Tractus Solitarius-A2 Cell Group: Role of ERK1/2
Endocrinology,
December 1, 2007;
148(12):
5780 - 5793.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. R. Parkitna, I. Obara, A. Wawrzczak-Bargiela, W. Makuch, B. Przewlocka, and R. Przewlocki
Effects of Glycogen Synthase Kinase 3beta and Cyclin-Dependent Kinase 5 Inhibitors on Morphine-Induced Analgesia and Tolerance in Rats
J. Pharmacol. Exp. Ther.,
November 1, 2006;
319(2):
832 - 839.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-M. Beaulieu, T. D. Sotnikova, R. R. Gainetdinov, and M. G. Caron
Paradoxical Striatal Cellular Signaling Responses to Psychostimulants in Hyperactive Mice
J. Biol. Chem.,
October 27, 2006;
281(43):
32072 - 32080.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Valjent, A.-G. Corbille, J. Bertran-Gonzalez, D. Herve, and J.-A. Girault
Inhibition of ERK pathway or protein synthesis during reexposure to drugs of abuse erases previously learned place preference
PNAS,
February 21, 2006;
103(8):
2932 - 2937.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Lesne, C. Gabriel, D. A. Nelson, E. White, E. T. MacKenzie, D. Vivien, and A. Buisson
Akt-dependent Expression of NAIP-1 Protects Neurons against Amyloid-{beta} Toxicity
J. Biol. Chem.,
July 1, 2005;
280(26):
24941 - 24947.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. G. Olson, C. P. Zabetian, C. A. Bolanos, S. Edwards, M. Barrot, A. J. Eisch, T. Hughes, D. W. Self, R. L. Neve, and E. J. Nestler
Regulation of Drug Reward by cAMP Response Element-Binding Protein: Evidence for Two Functionally Distinct Subregions of the Ventral Tegmental Area
J. Neurosci.,
June 8, 2005;
25(23):
5553 - 5562.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. A. Claude-Geppert, J. Liu, J. Solberg, L. J. Erickson-Herbrandson, H. H. Loh, and P.-Y. Law
Antagonist Efficacy in MORS196L Mutant Is Affected by the Interaction between Transmembrane Domains of the Opioid Receptor
J. Pharmacol. Exp. Ther.,
April 1, 2005;
313(1):
216 - 226.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. N. H. McGough, D.-Y. He, M. L. Logrip, J. Jeanblanc, K. Phamluong, K. Luong, V. Kharazia, P. H. Janak, and D. Ron
RACK1 and Brain-Derived Neurotrophic Factor: A Homeostatic Pathway That Regulates Alcohol Addiction
J. Neurosci.,
November 17, 2004;
24(46):
10542 - 10552.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Tegeder and G. Geisslinger
Opioids As Modulators of Cell Death and Survival--Unraveling Mechanisms and Revealing New Indications
Pharmacol. Rev.,
September 1, 2004;
56(3):
351 - 369.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Rajadhyaksha, I. Husson, S. S. Satpute, K. D. Kuppenbender, J. Q. Ren, R. M. Guerriero, D. G. Standaert, and B. E. Kosofsky
L-Type Ca2+ Channels Mediate Adaptation of Extracellular Signal-Regulated Kinase 1/2 Phosphorylation in the Ventral Tegmental Area after Chronic Amphetamine Treatment
J. Neurosci.,
August 25, 2004;
24(34):
7464 - 7476.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. L. Muller and E. M. Unterwald
In Vivo Regulation of Extracellular Signal-Regulated Protein Kinase (ERK) and Protein Kinase B (Akt) Phosphorylation by Acute and Chronic Morphine
J. Pharmacol. Exp. Ther.,
August 1, 2004;
310(2):
774 - 782.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Mizoguchi, K. Yamada, M. Mizuno, T. Mizuno, A. Nitta, Y. Noda, and T. Nabeshima
Regulations of Methamphetamine Reward by Extracellular Signal-Regulated Kinase 1/2/ets-Like Gene-1 Signaling Pathway via the Activation of Dopamine Receptors
Mol. Pharmacol.,
May 1, 2004;
65(5):
1293 - 1301.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
L. Zhang, D. Lou, H. Jiao, D. Zhang, X. Wang, Y. Xia, J. Zhang, and M. Xu
Cocaine-Induced Intracellular Signaling and Gene Expression Are Oppositely Regulated by the Dopamine D1 and D3 Receptors
J. Neurosci.,
March 31, 2004;
24(13):
3344 - 3354.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. M. Belcheva, Y. Tan, V. M. Heaton, A. L. Clark, and C. J. Coscia
{micro} Opioid Transactivation and Down-Regulation of the Epidermal Growth Factor Receptor in Astrocytes: Implications for Mitogen-Activated Protein Kinase Signaling
Mol. Pharmacol.,
December 1, 2003;
64(6):
1391 - 1401.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Eitan, C. D. Bryant, N. Saliminejad, Y. C. Yang, E. Vojdani, D. Keith Jr, R. Polakiewicz, and C. J. Evans
Brain Region-Specific Mechanisms for Acute Morphine-Induced Mitogen-Activated Protein Kinase Modulation and Distinct Patterns of Activation during Analgesic Tolerance and Locomotor Sensitization
J. Neurosci.,
September 10, 2003;
23(23):
8360 - 8369.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. A. Bolanos, L. I. Perrotti, S. Edwards, A. J. Eisch, M. Barrot, V. G. Olson, D. S. Russell, R. L. Neve, and E. J. Nestler
Phospholipase C{gamma} in Distinct Regions of the Ventral Tegmental Area Differentially Modulates Mood-Related Behaviors
J. Neurosci.,
August 20, 2003;
23(20):
7569 - 7576.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Eisinger, H. Ammer, and R. Schulz
Chronic Morphine Treatment Inhibits Opioid Receptor Desensitization and Internalization
J. Neurosci.,
December 1, 2002;
22(23):
10192 - 10200.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Fabian, B. Bozo, M. Szikszay, G. Horvath, C. J. Coscia, and M. Szucs
Chronic Morphine-Induced Changes in {micro}-Opioid Receptors and G Proteins of Different Subcellular Loci in Rat Brain
J. Pharmacol. Exp. Ther.,
August 1, 2002;
302(2):
774 - 780.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D.-Y. He, A. J. Vagts, R. Yaka, and D. Ron
Ethanol Induces Gene Expression via Nuclear Compartmentalization of Receptor for Activated C Kinase 1
Mol. Pharmacol.,
August 1, 2002;
62(2):
272 - 280.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Taylor and W. W. Fleming
Unifying Perspectives of the Mechanisms Underlying the Development of Tolerance and Physical Dependence to Opioids
J. Pharmacol. Exp. Ther.,
April 1, 2001;
297(1):
11 - 18.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
J. T. Williams, M. J. Christie, and O. Manzoni
Cellular and Synaptic Adaptations Mediating Opioid Dependence
Physiol Rev,
January 1, 2001;
81(1):
299 - 343.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Valjent, J.-C. Corvol, C. Pages, M.-J. Besson, R. Maldonado, and J. Caboche
Involvement of the Extracellular Signal-Regulated Kinase Cascade for Cocaine-Rewarding Properties
J. Neurosci.,
December 1, 2000;
20(23):
8701 - 8709.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. H. Tso and Y. H. Wong
Gz Can Mediate the Acute Actions of {micro}- and kappa -Opioids but Is Not Involved in Opioid-Induced Adenylyl Cyclase Supersensitization
J. Pharmacol. Exp. Ther.,
October 1, 2000;
295(1):
168 - 176.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
G. Cai, X. Zhen, K. Uryu, and E. Friedman
Activation of Extracellular Signal-Regulated Protein Kinases Is Associated with a Sensitized Locomotor Response to D2 Dopamine Receptor Stimulation in Unilateral 6-Hydroxydopamine-Lesioned Rats
J. Neurosci.,
March 1, 2000;
20(5):
1849 - 1857.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Henning, J. Silva, V. Reddy, S. Kamat, M. B. Morgan, Yong Xiang Li, and S. Chiou
Cocaine Increases {beta}-Myosin Heavy-Chain Protein Expression in Cardiac Myocytes
Journal of Cardiovascular Pharmacology and Therapeutics,
January 1, 2000;
5(4):
313 - 322.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. C. Pierce, A. F. Pierce-Bancroft, and B. M. Prasad
Neurotrophin-3 Contributes to the Initiation of Behavioral Sensitization to Cocaine by Activating the Ras/Mitogen-Activated Protein Kinase Signal Transduction Cascade
J. Neurosci.,
October 1, 1999;
19(19):
8685 - 8695.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. G. Ignatova, M. M. Belcheva, L. M. Bohn, M. C. Neuman, and C. J. Coscia
Requirement of Receptor Internalization for Opioid Stimulation of Mitogen-Activated Protein Kinase: Biochemical and Immunofluorescence Confocal Microscopic Evidence
J. Neurosci.,
January 1, 1999;
19(1):
56 - 63.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Numan, S. B. Lane-Ladd, L. Zhang, K. H. Lundgren, D. S. Russell, K. B. Seroogy, and E. J. Nestler
Differential Regulation of Neurotrophin and trk Receptor mRNAs in Catecholaminergic Nuclei during Chronic Opiate Treatment and Withdrawal
J. Neurosci.,
December 15, 1998;
18(24):
10700 - 10708.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Kawasaki, G. M. Springett, S. Toki, J. J. Canales, P. Harlan, J. P. Blumenstiel, E. J. Chen, I. A. Bany, N. Mochizuki, A. Ashbacher, et al.
A Rap guanine nucleotide exchange factor enriched highly in the basal ganglia
PNAS,
October 27, 1998;
95(22):
13278 - 13283.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X.-F. Zhang, X.-T. Hu, and F. J. White
Whole-Cell Plasticity in Cocaine Withdrawal: Reduced Sodium Currents in Nucleus Accumbens Neurons
J. Neurosci.,
January 1, 1998;
18(1):
488 - 498.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. B. Lane-Ladd, J. Pineda, V. A. Boundy, T. Pfeuffer, J. Krupinski, G. K. Aghajanian, and E. J. Nestler
CREB (cAMP Response Element-Binding Protein) in the Locus Coeruleus: Biochemical, Physiological, and Behavioral Evidence for a Role in Opiate Dependence
J. Neurosci.,
October 15, 1997;
17(20):
7890 - 7901.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. J. Nestler and G. K. Aghajanian
Molecular and Cellular Basis of Addiction
Science,
October 3, 1997;
278(5335):
58 - 63.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
W. A. Carlezon Jr., V. A. Boundy, C. N. Haile, S. B. Lane, R. G. Kalb, R. L. Neve, and E. J. Nestler
Sensitization to Morphine Induced by Viral-Mediated Gene Transfer
Science,
August 8, 1997;
277(5327):
812 - 815.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
M. T. Berhow, N. Hiroi, L. A. Kobierski, S. E. Hyman, and E. J. Nestler
Influence of Cocaine on the JAK-STAT Pathway in the Mesolimbic Dopamine System
J. Neurosci.,
December 15, 1996;
16(24):
8019 - 8026.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
